Examining how the Inflation Reduction Act affects insulin costs and diabetes care for Medicare patients
Insulin Affordability: Unpacking the Impact of the Inflation Reduction Act on Diabetes Outcomes and Equity in Medicare
['FUNDING_R01'] · YALE UNIVERSITY · NIH-11023634
This study looks at how the Inflation Reduction Act helps make insulin more affordable for people on Medicare, focusing on how capping out-of-pocket costs affects their health and access to diabetes care.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-11023634 on ClinicalTrials.gov |
What this research studies
This research investigates the effects of the Inflation Reduction Act on insulin affordability for Medicare beneficiaries. It aims to understand how capping out-of-pocket payments for insulin impacts health outcomes and equity in diabetes care. By analyzing data from Medicare claims and other sources, the study will evaluate changes in insulin utilization and clinical outcomes before and after the implementation of the Act. The goal is to identify barriers to diabetes care and propose effective solutions for improving access to insulin.
Who could benefit from this research
Good fit: Ideal candidates for this research are Medicare beneficiaries aged 65 and older who require insulin for managing their diabetes.
Not a fit: Patients who are not enrolled in Medicare or do not require insulin for diabetes management may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to insulin and better health outcomes for Medicare patients with diabetes.
How similar studies have performed: Previous research has shown that policy changes affecting medication costs can significantly improve access and health outcomes for patients, suggesting potential success for this approach.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIPSKA, KASIA JOANNA — YALE UNIVERSITY
- Study coordinator: LIPSKA, KASIA JOANNA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: adult onset diabetes